Inventor
AUDOLY LAURENT
US12 patents
⚠️ This page may combine multiple inventors who share the name “AUDOLY LAURENT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PIERIS PHARMACEUTICALS GMBH
10 patentsUS10857202B2Dec 8, 2020
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
PIERIS PHARMACEUTICALS GMBH4 citations82
US10526382B2Jan 7, 2020
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof
PIERIS PHARMACEUTICALS GMBH6 citations82
US10398754B2Sep 3, 2019
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
PIERIS PHARMACEUTICALS GMBH4 citations82
US10016483B2Jul 10, 2018
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
PIERIS PHARMACEUTICALS GMBH6 citations82
US9572863B2Feb 21, 2017
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
PIERIS PHARMACEUTICALS GMBH4 citations82
US9610356B2Apr 4, 2017
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
PIERIS PHARMACEUTICALS GMBH7 citations79
US10526384B2Jan 7, 2020
Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
PIERIS PHARMACEUTICALS GMBH5 citations72
US11382951B2Jul 12, 2022
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
PIERIS PHARMACEUTICALS GMBH2 citations71
US9950034B2Apr 24, 2018
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
PIERIS PHARMACEUTICALS GMBH3 citations71
US11034738B2Jun 15, 2021
Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)
PIERIS PHARMACEUTICALS GMBH0 citations61